Capital International Inc’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.6M | Buy |
78,728
+24,176
| +44% | +$9.4M | 0.3% | 91 |
|
|
2025
Q1 | $23.7M | Buy |
54,552
+10,163
| +23% | +$4.42M | 0.29% | 98 |
|
|
2024
Q4 | $16.4M | Buy |
44,389
+6,104
| +16% | +$2.25M | 0.19% | 130 |
|
|
2024
Q3 | $19.9M | Buy |
38,285
+1,365
| +4% | +$710K | 0.25% | 109 |
|
|
2024
Q2 | $20M | Buy |
36,920
+1,328
| +4% | +$720K | 0.27% | 104 |
|
|
2024
Q1 | $18.5M | Buy |
35,592
+2,960
| +9% | +$1.53M | 0.25% | 115 |
|
|
2023
Q4 | $15.4M | Buy |
32,632
+4,709
| +17% | +$2.22M | 0.24% | 120 |
|
|
2023
Q3 | $12.2M | Sell |
27,923
-10,693
| -28% | -$4.66M | 0.23% | 123 |
|
|
2023
Q2 | $17.2M | Buy |
38,616
+3,175
| +9% | +$1.41M | 0.31% | 96 |
|
|
2023
Q1 | $16.3M | Sell |
35,441
-872
| -2% | -$401K | 0.33% | 93 |
|
|
2022
Q4 | $18.6M | Buy |
36,313
+278
| +0.8% | +$143K | 0.4% | 78 |
|
|
2022
Q3 | $16.4M | Sell |
36,035
-48,761
| -58% | -$22.1M | 0.37% | 84 |
|
|
2022
Q2 | $40.9M | Sell |
84,796
-6,476
| -7% | -$3.13M | 0.57% | 59 |
|
|
2022
Q1 | $44.8M | Sell |
91,272
-4,185
| -4% | -$2.06M | 0.5% | 73 |
|
|
2021
Q4 | $44.2M | Sell |
95,457
-698
| -0.7% | -$324K | 0.41% | 81 |
|
|
2021
Q3 | $35.8M | Sell |
96,155
-14,115
| -13% | -$5.26M | 0.35% | 93 |
|
|
2021
Q2 | $42.1M | Sell |
110,270
-8,721
| -7% | -$3.33M | 0.38% | 95 |
|
|
2021
Q1 | $42.7M | Sell |
118,991
-12,990
| -10% | -$4.66M | 0.4% | 89 |
|
|
2020
Q4 | $42.4M | Sell |
131,981
-465
| -0.4% | -$149K | 0.39% | 94 |
|
|
2020
Q3 | $35.6M | Sell |
132,446
-16,249
| -11% | -$4.36M | 0.39% | 93 |
|
|
2020
Q2 | $39.1M | Buy |
148,695
+2,644
| +2% | +$695K | 0.48% | 77 |
|
|
2020
Q1 | $33.2M | Buy |
146,051
+3,524
| +2% | +$800K | 0.56% | 71 |
|
|
2019
Q4 | $43M | Buy |
142,527
+12,960
| +10% | +$3.91M | 0.6% | 75 |
|
|
2019
Q3 | $31.1M | Buy |
129,567
+126,730
| +4,467% | +$30.4M | 0.47% | 89 |
|
|
2019
Q2 | $801K | Buy |
+2,837
| New | +$801K | 0.06% | 166 |
|